CAPR vs. QVCGA
CAPR (Capricor Therapeutics, Inc.) and QVCGA (QVC Group Inc) are both stocks. CAPR operates in Biotechnology (Healthcare), while QVCGA operates in Internet Retail (Consumer Cyclical).
Performance
CAPR vs. QVCGA - Performance Comparison
Loading charts...
Returns By Period
CAPR
- 1D
- -8.11%
- 1M
- -83.41%
- 6M
- -82.41%
- YTD
- -86.66%
- 1Y
- -51.27%
- 3Y*
- -5.69%
- 5Y*
- -2.50%
- 10Y*
- -20.36%
- ALL TIME*
- -24.85%
QVCGA
- 1D
- 0.00%
- 1M
- 0.00%
- 6M
- —
- YTD
- —
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
- ALL TIME*
- —
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $66.47M | $47.41M | $39.47M | |
QVCGA QVC Group Inc | $0.00 | $0.00 | $0.00 |
CAPR vs. QVCGA - Yearly Performance Comparison
| 2026 (YTD) | |
|---|---|
CAPR Capricor Therapeutics, Inc. | -86.79% |
QVCGA QVC Group Inc | 0.00% |
Fundamentals
CAPR:
$222.96M
QVCGA:
$2.69M
CAPR:
-$2.26
QVCGA:
-$301.98
CAPR:
$0.00
QVCGA:
$9.23B
CAPR:
-$42.41M
QVCGA:
$2.89B
CAPR:
-$117.24M
QVCGA:
$789.00M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CAPR vs. QVCGA — Risk / Return Rank
CAPR
QVCGA
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
CAPR vs. QVCGA - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Capricor Therapeutics, Inc. (CAPR) and QVC Group Inc (QVCGA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CAPR | QVCGA | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | — | — | |
| Sortino ratioReturn per unit of downside risk | — | — | |
| Omega ratioGain probability vs. loss probability | 1.38 | — | — |
| Calmar ratioReturn relative to maximum drawdown | -0.60 | — | — |
| Martin ratioReturn relative to average drawdown | -2.06 | — | — |
Loading charts...
Drawdowns
CAPR vs. QVCGA - Drawdown Comparison
The maximum CAPR drawdown since its inception was -99.97%, which is greater than QVCGA's maximum drawdown of 0.00%. Use the drawdown chart below to compare losses from any high point for CAPR and QVCGA.
Loading charts...
Drawdown Indicators
| CAPR | QVCGA | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.97% | 0.00% | -99.97% |
Max Drawdown (1Y)Largest decline over 1 year | -89.11% | — | — |
Max Drawdown (3Y)Largest decline over 3 years | -89.11% | — | — |
Max Drawdown (5Y)Largest decline over 5 years | -89.11% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -97.70% | — | — |
Current DrawdownCurrent decline from peak | -99.88% | 0.00% | -99.88% |
Average DrawdownAverage peak-to-trough decline | -90.30% | 0.00% | -90.30% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 25.74% | — | — |
Volatility
CAPR vs. QVCGA - Volatility Comparison
Loading charts...
Volatility by Period
| CAPR | QVCGA | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 109.75% | — | — |
Volatility (6M)Calculated over the trailing 6-month period | 122.98% | — | — |
Volatility (1Y)Calculated over the trailing 1-year period | 387.50% | 0.00% | +387.50% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 192.92% | 0.00% | +192.92% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 181.22% | 0.00% | +181.22% |
Dividends
CAPR vs. QVCGA - Dividend Comparison
Neither CAPR nor QVCGA has paid dividends to shareholders.
Financials
CAPR vs. QVCGA - Financials Comparison
This section allows you to compare key financial metrics between Capricor Therapeutics, Inc. and QVC Group Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Find the right allocation for CAPR and QVCGA
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer